CD8+, and CD16/56+ lymphocytes formed conjugates with C. neoformans, as observed under Nomarski differential interference contrast microscopy and videomicroscopy. These data demonstrate that freshly isolated peripheral blood T cells and NK cells have the capacity to bind and directly inhibit the growth of C. neoformans.
The yeast Cryptococcus neoformans has a marked propensity to cause infections in patients with impaired T-cell function, such as those with AIDS, lymphoreticular malignancy, and idiopathic CD4+ lymphocytopenia and recipients of corticosteroid therapy (3, 5, 19, 34) . In particular, cryptococcosis has emerged as one of the most frequent lifethreatening infections in patients with AIDS, afflicting at least 5 to 10% of AIDS patients in the United States and an even higher percentage in parts of the developing world (3, 19, 34) . The strong association of human cryptococcosis with disorders of T lymphocytes (especially CD4+ T cells) points to a critical role for this cell type in cryptococcal host defenses.
In murine models of cryptococcosis, pulmonary inoculation of C. neoformans results in an influx of both CD4+ and CD8+ T cells. Mice depleted of either CD4+ or CD8+ cells have been noted to have impaired clearance and increased susceptibility to systemic dissemination when challenged intratracheally with C. neoformans (11, 12, 14, 29) . How the T lymphocyte contributes to the immune response against C. neoformans remains incompletely defined and is probably multifactorial. Cytokines (e.g., gamma interferon and interleukin-4 [IL-4]) secreted by activated T lymphocytes may capacitate macrophages and possibly other cell types for increased fungicidal capacity and/or confinement of the yeast within multinucleated giant cells (6, 11, 20 we demonstrated another potential mechanism by which T cells may promote host defenses against cryptococcosis: highly purified IL-2-activated human lymphocytes expressing T-cell or natural killer (NK) cell surface markers formed conjugates with and directly inhibited the growth of C. neofornans in the absence of MHC restriction (22) . In the present study, we examine the anticryptococcal activity of freshly isolated human peripheral blood T cells and NK cells.
(Some of the data contained in this article were presented at the 93rd Annual Meeting of the American Society for Microbiology, Atlanta, Ga., 16-20 May 1993 Antifungal activity of cultured PBMC. Antifungal activity was determined as described previously (18, (22) (23) (24) (18, (22) (23) (24) .
Detection of cell surface antigens. Expression of specific cell surface markers was determined by flow cytometric analysis (FACScan; Becton Dickinson, Mountain View, Calif.) of fluorescein-stained cells (22, 24) . The MAb used to detect the indicated cell surface antigens were as follows: T3 (CD3, T cells); T4 (CD4, T-cell subset), Ti NWNA PBMC were intrinsically fungistatic. During culture without IL-2, this fungistatic capacity progressively waned. However, culture with IL-2 prevented the decline in fungistatic activity. Subsequent experiments focused on defining the component of the freshly isolated NWNA PBMC that was responsible for anticryptococcal activity.
Effect of rosetting. In the next set of experiments, NWNA PBMC were further fractionated by their ability to form rosettes with SE and then tested for activity against two strains of C. neoformans. As determined by flow cytometry, the rosetted cells averaged 79% T cells, 20% NK cells, 0% B cells, and 0% monocytes, while the cells in the interface (nonrosetting cells) averaged 0% T cells, 35% NK cells, 0% B cells, and 0% monocytes. (Approximately 65% of the cells in the interface did not stain for T, NK, B, or monocyte markers). The cells in the rosette fraction retained growthinhibitory activity against both strains of C. neoformans tested, whereas cells in the interface had greatly diminished antifungal capacity (Fig. 2) .
Negative selection by panning. The previous experiments, while strongly suggesting that T cells and/or NK cells had anticryptococcal activity, did not shed light on which population of cells was responsible. Therefore, in the next sets of experiments, the anticryptococcal activity of NWNA PBMC depleted of either NK cells or T cells by negative selection (Fig. 4) .
Effect of LME and activity of B cells. The finding that both T lymphocytes and NK cells had anticryptococcal activity raised the possibility that all lymphocytes had anticryptococcal activity. To examine this possibility, PBMC were depleted of monocytes, NK cells, and cytotoxic T lymphocytes by treatment with LME (37, 39 procedure proved to be very efficient; 96% of the rosetting cells expressed the T-cell marker CD3, whereas 83% of the nonrosetting (interface) cells expressed the B-cell marker CD20 ( Table 3 ). As expected, PBMC had excellent antifungal activity against strains B3501 and 145 (Fig. 5) . Most of the antifungal activity was abolished after treatment with LME. When the LME-treated PBMC were further separated into T-cell and B-cell fractions by rosetting with SE, only modest antifungal activity was seen in the T-cell fraction and no significant activity was seen in the B-cell fraction. perhaps some T cells possess receptors for complement and Ig (36, 42) . Moreover, for many cell types, opsonization with complement and/or antibody is required for immune recognition of encapsulated C. neoformans (17, 25) . Therefore, we next studied the effect that various opsonic conditions would have on the ability of NWNA PBMC to inhibit the growth of two strains of C. neoformans (Fig. 6) . Compared with growth inhibition in wells containing PHS alone, the addition of serotype-specific rabbit polyclonal anticryptococcal antibody and heat inactivation of serum had little or no effect on growth inhibition. For strain 145, there was a slight increase in growth when serum and antibody were omitted from the system altogether. For strain B3501, the effects of the omission of opsonins were difficult to gauge because, consistent with previous reports (13) , fungal growth was increased more than threefold in wells lacking serum compared with growth in wells containing serum. Nevertheless, in the absence of opsonins, growth was 77% lower in wells containing NWNA PBMC than in wells lacking NWNA PBMC.
Activity of supernatants and cell lysates. To explore the possibility that the growth inhibition observed in the above experiments was secondary either to depletion of nutrients from the medium or to release of a preformed antifungal substance, the activity of supernatants and cell lysates derived from NWNA PBMC was assayed. Three separate experiments were performed with strains B3501 and 145. Compared with cryptococcal growth in wells containing medium alone, neither supematants (stimulated or unstimulated) nor lysates had growth-inhibitory activity (data not shown).
Effect of proteases. We next examined whether the anticryptococcal activity of NWNA PBMC would be affected by treatment with bromelain or trypsin, two proteases known to cleave some (but not all) lymphocytic receptors (8, 25) . Preliminary experiments with flow cytometry established the effectiveness of protease treatment: trypsinization of NWNA PBMC diminished the expression of CD4, CD8, and CD56 by >90% while leaving expression of CD3 unaffected. After bromelain treatment, lymphocytic expression of CD8 and CD56 was reduced by >90%, whereas expression of CD3 and CD4 was unchanged. Treatment of NWNA PBMC with either protease significantly and profoundly diminished the capacity of those cells to inhibit the growth of cryptococcal strains B3501 and 145 (Fig. 7) . The viability of lymphocytes 24 h after protease treatment was 93% + 1%, 89% + 4% and 60% + 7% (mean + SEM for three separate experiments) for untreated, trypsin-treated, and bromelaintreated cells, respectively.
Nomarski DIC microscopy. Lymphocytes enriched for CD4+, CD8+, or CD16/56+ cells by positive selection were incubated with C. neofonnans for 2 h in medium containing 10% PHS and then fixed by immersion in methanol at -20°C for 20 s followed by three dips in acetone at -20°C. Cells were observed at 1,OOOx magnification by Nomarski DIC microscopy. Granules and cell boundaries are particularly well visualized by this technique. Conjugates, which were seen with all three cell types, consisted mostly of one to three lymphocytes in intimate contact with C. neoformans (Fig. 8) . As would be expected for CD4+ lymphocytes, these cells were relatively devoid of granules. In contrast, conjugates between CD8+ or CD16/56+ lymphocytes and C. neofornans tended to be composed of granule-containing lymphocytes. For conjugates containing granular lymphocytes, the granules were usually found concentrated on or in proximity to the capsular surface of C. neoformans. In one representative experiment performed in duplicate, 21, 9, and 13% of CD4+, CD8+, and CD16/56+ lymphocytes, respectively, were conjugated with one or more C. neoformans cells. Actual phagocytosis (internalization) of organisms was never seen; rather, the lymphocytic membrane could be seen in intimate contact with the capsular surface of the fungus.
Videomicroscopy. In the final set of experiments, NWNA PBMC incubated at 37°C with C. neoformans in the presence of 10% PHS were observed by videomicroscopy. As in previous experiments with IL-2-activated lymphocytes (22) (16, 26, 27, 35, 40) . Murphy and colleagues have demonstrated binding, growth inhibition, and killing of C. neofonnans by murine NK cells (10, 31, 32) , and in agreement with our studies, recently presented data extending these findings to human NK and T lymphocytes (30) . However, two other laboratories failed to demonstrate cryptococcal fungistasis mediated by human NK or T-cell populations in the absence of anticryptococcal antibody (4, 28) . The reasons for these interlaboratory disparities are not entirely clear but could relate to differences in cell densities or culture conditions. In this regard, the two laboratories demonstrating human lymphocyte-mediated fungistasis used 106 effector cells per well (present study and reference 30), whereas a lower cell density was used by the other laboratories (4, 28) . The interlaboratory disparities are not a result of strain variation, since lymphocyte-mediated inhibition of strain 145 occurred in our studies but not those of Miller et al. (28) .
Our findings that lymphocytes treated with trypsin or bromelain had markedly impaired fungistatic capacity suggest that specific receptor-ligand interactions are necessary prerequisites for fungistasis. Since numerous receptors are cleaved by these two proteases (8, 25) , future studies will be needed to determine the specific receptor(s) on lymphocytes that is responsible for this interaction. In addition to receptor cleavage, some of the inhibitory effects of bromelain (but not trypsin) may have been secondary to the decreased viability of lymphocytes treated with that protease. Our data showing that both T cells and NK cells are capable of mediating fungistasis suggest that a receptor common to both of these cell types is likely to be essential for recognition or signal transduction. As in our previous studies with IL-2-activated lymphocytes (22) granules that can be discharged after exposure to target cells. Granule exocytosis releases preformed substances with potential effector activity, including perforin, serine esterases (granzymes), and chondroitin sulfate (36) . Observations of lymphocyte-C. neoformans interactions under Nomarski DIC microscopy demonstrate that granule exocytosis occurs during conjugate formation. Moreover, monensin, an inhibitor of granule secretion, partially inhibits fungistasis (21) . However, there is strong evidence that certain tumor targets can be lysed by NK cells and cytotoxic T lymphocytes in the absence of granule secretion (2, 7, 41).
Our demonstration that CD4+ lymphocytes, most of which are relatively agranular, can mediate binding and fungistasis suggests that granule-independent mechanisms of fungistasis are also operative. In support of this concept, after fractionation of rat LGL tumor cells, anticryptococcal activity was found not only in the granule fraction but also in three cytoplasmic fractions (9) .
Lymphocyte supernatants did not have measurable antifungal activity in our experiments. These data, together with those from the protease experiments, effectively rule out the possibility that lymphocyte consumption of a factor(s) essential to fungal growth was responsible for fungistasis. The inability of concentrated lymphocyte lysates to effect antifungal activity suggests that the mediator(s) of fungistasis is (i) generated after activation, (ii) short lived, and/or (iii) preferentially active in the local environment created in the course of conjugate formation.
Because of the nature of the assay used, it is difficult to determine whether, in addition to mediating fungistasis, the lymphocytes killed some of the fungal inoculum. This is because over the 24 h of incubation, some of the fungi may have reproduced while others were killed. For many of the experiments with cryptococcal strain B3501 (but not strain 145), there was a decrease in CFU over the course of the incubation, indicating that some fungicidal activity had occurred. When the incubation period was shortened to 2 h, significant fungicidal activity was not observed (21) .
It remains to be determined whether our findings have in vivo correlates. Lymphocytes are commonly found in proximity to extracellular C. neoformans in lesions in immunocompetent patients recovering from cryptococcosis (1, 21) and in normal mice experimentally inoculated with C. neoformans (11) . Although a relatively high effector-to-target cell ratio was required in order to see maximal activity in our system, specifically recruited lymphocytes functioning in a physiological milieu in vivo may have activity at lower effector-to-target cell ratio. Moreover, lymphocytes may act synergistically with neutrophils, monocytes, and/or macrophages (cell types known to have antifungal activity [6, 18, 20, 23, 24, 28] ) to contain the fungal burden. Finally, although the studies reported here focused on fungistasis, ongoing studies in our laboratory are examining the possibility that lymphocytes directly stimulated by C. neoformans may also participate in host defenses by releasing cytokines or other modulators of the inflammatory response.
